Characteristics and Long-Term Outcomes of Asymptomatic Corticotroph Adenomas: A Retrospective Analysis of Clinical, Radiological, and Pathological Data - Scorecard - DentalSpire

Characteristics and Long-Term Outcomes of Asymptomatic Corticotroph Adenomas: A Retrospective Analysis of Clinical, Radiological, and Pathological Data

  • By

  • Yuhui Chen

  • Yang Yang

  • Heng Zhang

  • Tianshun Feng

  • Liangfeng Wei

  • Shousen Wang

  • December 1, 2025

  • 0 min

Share

Clinical Scorecard: Characteristics and Long-Term Outcomes of Asymptomatic Corticotroph Adenomas: A Retrospective Analysis of Clinical, Radiological, and Pathological Data

At a Glance

CategoryDetail
ConditionSilent Corticotroph Adenomas (SCAs)
Key MechanismsOriginating from ACTH-producing cells, often misclassified due to overlapping features with other non-functioning pituitary adenomas. Prevalence data should be included.
Target PopulationPatients diagnosed with non-functioning pituitary adenomas (NFPAs) undergoing surgery.
Care SettingLarge neurosurgical center.

Key Highlights

  • SCAs account for a notable subtype of NFPAs with invasive behavior and higher recurrence rates. Accurate preoperative identification of SCAs is essential for guiding treatment decisions.
  • Certain SCAs may evolve into functional adenomas over time.

Guideline-Based Recommendations

Diagnosis

  • Preoperative endocrine testing for hormone levels to exclude hypercortisolism.
  • MRI evaluation for tumor characteristics, including specific imaging techniques.

Management

  • Surgical intervention is indicated for SCAs with invasive behavior.

Monitoring & Follow-up

  • Regular follow-up with MRI to assess for tumor recurrence, detailing the monitoring process.

Risks

  • Higher risk of postoperative recurrence compared to other NFPAs.

Patient & Prescribing Data

Adults diagnosed with NFPAs without hyperpituitarism.

Surgical resection is the primary treatment, with careful monitoring for recurrence.

Clinical Best Practices

  • Utilize comprehensive preoperative imaging and endocrine evaluation.
  • Ensure thorough postoperative follow-up to monitor for recurrence, involving a multidisciplinary team.

Related Resources & Content

Original Source(s)

Related Content